Natural killer cells become tolerogenic after interaction with apoptotic cells

European Journal of Immunology

Volumn 40, Issue 6, 2010, Pages 1718-1727

  Chong, Wai Po ^a   Zhou, Jianfang ^a,b   Law, Helen K W ^a,c   Tu, Wenwei ^a   Lau, Yu Lung ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b NATIONAL INSTITUTE FOR VIRAL DISEASE CONTROL AND PREVENTION   (China)

^c INSTITUT PASTEUR   (France)

Author keywords

Apoptosis; NK cells; Tolerance

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN G; INTERLEUKIN 12; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; PHOSPHATIDYLSERINE; TRANSFORMING GROWTH FACTOR BETA1; VIMENTIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL INTERACTION; CELL STIMULATION; CELL STRUCTURE; CELL SURFACE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; IMMUNOLOGICAL TOLERANCE; LEUKEMIA CELL LINE; LYMPHOCYTE PROLIFERATION; LYSIS; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TARGET CELL;

APOPTOSIS; CD4-POSITIVE T-LYMPHOCYTES; CELL SEPARATION; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; IMMUNE TOLERANCE; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 77953317694     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200939768     Document Type: Article

References (39)

1. Held, W., Tolerance and reactivity of NK cells: two sides of the same coin? Eur. J. Immunol. 2008. 38: 2930-2933.
2. Andoniou, C. E., Coudert, J. D. and Degli-Esposti, M. A., Killers and beyond: NK-cell-mediated control of immune responses. Eur. J. Immunol. 2008. 38: 2938-2942.
3. Cooper, M. A., Fehniger, T. A. and Caligiuri, M. A., The biology of human natural killer-cell subsets. Trends Immunol. 2001. 22: 633-640.
4. Martin-Fontecha, A., Thomsen, L. L., Brett, S., Gerard, C., Lipp, M., Lanzavecchia, A. and Sallusto, F., Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat. Immunol. 2004. 5: 1260-1265.
5. Hanna, J., Gonen-Gross, T., Fitchett, J., Rowe, T., Daniels, M., Arnon, T. I., Gazit, R. et al., Novel APC-like properties of human NK cells directly regulate T cell activation. J. Clin. Invest. 2004. 114: 1612-1623.
6. Grunebaum, E., Malatzky-Goshen, E. and Shoenfeld, Y., Natural killer cells and autoimmunity. Immunol. Res. 1989. 8: 292-304.
7. Perricone, R., Perricone, C., De Carolis, C. and Shoenfeld, Y., NK cells in autoimmunity: a two-edged weapon of the immune system. Autoimmun. Rev. 2008. 7: 384-390.
8. Abe, M., Harpel, J. G., Metz, C. N., Nunes, I., Loskutoff, D. J. and Rifkin, D. B., An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. Anal. Biochem. 1994. 216: 276-284.
9. Gray, J. D., Hirokawa, M., Ohtsuka, K. and Horwitz, D. A., Generation of an inhibitory circuit involving CD8+ T cells, IL-2, and NK cell-derived TGF-beta: contrasting effects of anti-CD2 and anti-CD3. J. Immunol. 1998. 160: 2248-2254.
10. Ghio, M., Contini, P., Negrini, S., Boero, S., Musso, A. and Poggi, A., Soluble HLA-I-mediated secretion of TGF-beta1 by human NK cells and consequent down-regulation of anti-tumor cytolytic activity. Eur. J. Immunol. 2009. 39: 3459-3468.
11. Laouar, Y., Sutterwala, F. S., Gorelik, L. and Flavell, R. A., Transforming growth factor-beta controls T helper type 1 cell development through regulation of natural killer cell interferon-gamma. Nat. Immunol. 2005. 6: 600-607.
12. Moretta, L., Ferlazzo, G., Bottino, C., Vitale, M., Pende, D., Mingari, M. C. and Moretta, A. H., Effector and regulatory events during natural killer-dendritic cell interactions. Immunol. Rev. 2006. 214: 219-228.
13. Xu, W., Fazekas, G., Hara, H. and Tabira, T., Mechanism of natural killer (NK) cell regulatory role in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 2005. 163: 24-30.
14. Zhang, B., Yamamura, T., Kondo, T., Fujiwara, M. and Tabira, T., Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells. J. Exp. Med. 1997. 186: 1677-1687.
15. Cerboni, C., Zingoni, A., Cippitelli, M., Piccoli, M., Frati, L. and Santoni, A ., Antigen-activated human T lymphocytes express cell surface NKG2D ligands via an ATM/ATR-dependent mechanism and become susceptible to autologous NK cell lysis. Blood 2007. 110: 606-615.
16. Fadok, V. A., Bratton, D. L., Konowal, A., Freed, P. W., Westcott, J. Y. and Henson, P. M ., Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J. Clin. Invest. 1998. 101: 890-898.
17. Morelli, A. E., Larregina, A. T., Shufesky, W. J., Zahorchak, A. F., Logar, A. J., Papworth, G. D., Wang, Z. et al., Internalization of circulating apoptotic cells by splenic marginal zone dendritic cells: dependence on complement receptors and effect on cytokine production. Blood 2003. 101:611-620.
18. Ip, W. K. and Lau, Y. L., Distinct maturation of, but not migration between, human monocyte-derived dendritic cells upon ingestion of apoptotic cells of early or late phases. J. Immunol. 2004. 173:189-196.
19. Huynh, M. L., Fadok, V. A. and Henson, P. M., Phosphatidylserine- dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation. J. Clin. Invest. 2002. 109: 41-50.
20. Steinman, R. M., Hawiger, D. and Nussenzweig, M. C., Tolerogenic dendritic cells. Annu. Rev. Immunol. 2003. 21: 685-711.
21. Gibboney, J. J., Shenoy, A. M., Jin, X. and Brahmi, Z., Signal transduction in activated natural killer cells and natural killer cells inactivated with sensitive targets. Nat. Immun. 1992. 11: 57-68.
22. Shenoy, A. M., Sidner, R. A. and Brahmi, Z., Signal transduction in cytotoxic lymphocytes: decreased calcium influx in NK cell inactivated with sensitive target cells. Cell Immunol. 1993. 147: 294-301.
23. Ghiringhelli, F., Ménard, C., Terme, M., Flament, C., Taieb, J., Chaput, N., Puig, P. E. et al., CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner. J. Exp. Med. 2005. 202: 1075-1085.
24. Fadok, V. A., Voelker, D. R., Campbell, P. A., Cohen, J. J., Bratton, D. L. and Henson, P. M., Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol. 1992. 148: 2207-2216.
25. Li, M. O., Wan, Y. Y., Sanjabi, S., Robertson, A. K. and Flavell, R. A., Transforming growth factor-beta regulation of immune responses. Annu. Rev. Immunol. 2006. 24: 99-146.
26. Shi, F. D. and Van Kaer, L., Reciprocal regulation between natural killer cells and autoreactive T cells. Nat Rev Immunol. 2006. 6:751-760 (Pubitemid 44453461)
27. Nolte-'t Hoen, E. N., Almeida, C. R., Cohen, N. R., Nedvetzki, S., Yarwood, H. and Davis, D. M., Increased surveillance of cells in mitosis by human NK cells suggests a novel strategy for limiting tumor growth and viral replication. Blood 2007. 109: 670-673.
28. Huet, D., Bagot, M., Loyaux, D., Capdevielle, J., Conraux, L., Ferrara, P., Bensussan, A . et al., SC5 mAb represents a unique tool for the detection of extracellular vimentin as a specific marker of Sezary cells. J. Immunol. 2006. 176: 652-659. (Pubitemid 43023314)
29. Mor-Vaknin, N., Punturieri, A., Sitwala, K. and Markovitz, D. M., Vimentin is secreted by activated macrophages. Nat. Cell. Biol. 2003. 5: 59-63.
30. Garg, A., Barnes, P. F., Porgador, A., Roy, S., Wu, S., Nanda, J. S., Griffith, D. E. et al., Vimentin expressed on Mycobacterium tuberculosis- infected human monocytes is involved in binding to the NKp46 receptor. J. Immunol. 2006. 177: 6192-6198. (Pubitemid 44628837)
31. Bussolati, B., Mariano, F., Cignetti, A., Guarini, A., Cambi, V., Foà, R., Piccoli, G. et al., Platelet-activating factor synthesized by IL-12-stimulated polymorphonuclear neutrophils and NK cells mediates chemotaxis. J. Immunol. 1998. 161: 1493-1500. (Pubitemid 28380582)
32. Grimsley, C. and Ravichandran, K. S., Cues for apoptotic cell engulfment: eat-me, don't eat-me and come-get-me signals. Trends Cell. Biol. 2003. 13: 648-656.
33. McDonald, P. P., Fadok, V. A., Bratton, D. and Henson, P. M., Transcriptional and translational regulation of inflammatory mediator production by endogenous TGF-b in macrophages that have ingested apoptotic cells. J. Immunol. 1999. 163: 6164-6172.
34. Magor, B. G. and Magor, K. E., Evolution of effectors and receptors of innate immunity. Dev. Comp. Immunol. 2001. 25: 651-682.
35. Blach-Olszewska, Z., Innate immunity: cells, receptors, and signaling pathways. Arch Immunol. Ther. Exp. 2005. 53: 245-253.
36. Castriconi, R., Cantoni, C., Della Chiesa, M., Vitale, M., Marcenaro, E., Conte, R., Biassoni, R. et al., Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells. Proc. Natl. Acad. Sci. USA 2003. 100: 4120-4125.
37. Fischer, A., Latour, S. and de Saint Basile, G., Genetic defects affecting lymphocyte cytotoxicity. Curr. Opin. Immunol. 2007. 19: 348-353.
38. Tu, W., Cheung, P. T. and Lau, Y. L., IGF-I increases interferon-gamma and IL-6 mRNA expression and protein production in neonatal mononuclear cells. Pediatr. Res. 1999. 46: 748-754.
39. Tu, W., Zhang, D. K., Cheung, P. T., Tsao, S. W. and Lau, Y. L., Effect of insulin-like growth factor 1 on PHA-stimulated cord blood mononuclear cell telomerase activity. Br. J. Haematol. 1999. 104: 785-794.